These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 16546435)
1. Enhanced porphyrin accumulation using dendritic derivatives of 5-aminolaevulinic acid for photodynamic therapy: an in vitro study. Battah S; O'Neill S; Edwards C; Balaratnam S; Dobbin P; MacRobert AJ Int J Biochem Cell Biol; 2006; 38(8):1382-92. PubMed ID: 16546435 [TBL] [Abstract][Full Text] [Related]
2. Macromolecular delivery of 5-aminolaevulinic acid for photodynamic therapy using dendrimer conjugates. Battah S; Balaratnam S; Casas A; O'Neill S; Edwards C; Batlle A; Dobbin P; MacRobert AJ Mol Cancer Ther; 2007 Mar; 6(3):876-85. PubMed ID: 17363482 [TBL] [Abstract][Full Text] [Related]
3. 5-Aminolaevulinic acid peptide prodrugs enhance photosensitization for photodynamic therapy. Bourré L; Giuntini F; Eggleston IM; Wilson M; MacRobert AJ Mol Cancer Ther; 2008 Jun; 7(6):1720-9. PubMed ID: 18566243 [TBL] [Abstract][Full Text] [Related]
4. Investigation of a novel dendritic derivative of 5-aminolaevulinic acid for photodynamic therapy. Di Venosa GM; Casas AG; Battah S; Dobbin P; Fukuda H; Macrobert AJ; Batlle A Int J Biochem Cell Biol; 2006 Jan; 38(1):82-91. PubMed ID: 16172016 [TBL] [Abstract][Full Text] [Related]
5. Sustained and efficient porphyrin generation in vivo using dendrimer conjugates of 5-ALA for photodynamic therapy. Casas A; Battah S; Di Venosa G; Dobbin P; Rodriguez L; Fukuda H; Batlle A; MacRobert AJ J Control Release; 2009 Apr; 135(2):136-43. PubMed ID: 19168101 [TBL] [Abstract][Full Text] [Related]
6. Aminolevulinic acid dendrimers in photodynamic treatment of cancer and atheromatous disease. Rodriguez L; Vallecorsa P; Battah S; Di Venosa G; Calvo G; Mamone L; Sáenz D; Gonzalez MC; Batlle A; MacRobert AJ; Casas A Photochem Photobiol Sci; 2015 Sep; 14(9):1617-27. PubMed ID: 26066768 [TBL] [Abstract][Full Text] [Related]
7. Porphyrin accumulation induced by 5-aminolaevulinic acid esters in tumour cells growing in vitro and in vivo. Tunstall RG; Barnett AA; Schofield J; Griffiths J; Vernon DI; Brown SB; Roberts DJ Br J Cancer; 2002 Jul; 87(2):246-50. PubMed ID: 12107850 [TBL] [Abstract][Full Text] [Related]
8. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester. Gerscher S; Connelly JP; Beijersbergen Van Henegouwen GM; MacRobert AJ; Watt P; Rhodes LE Br J Dermatol; 2001 May; 144(5):983-90. PubMed ID: 11359385 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of 5-aminolaevulinic acid/3-hydroxypyridinone conjugates as potential photodynamic therapeutical agents. Zhu CF; Battah S; Kong X; Reeder BJ; Hider RC; Zhou T Bioorg Med Chem Lett; 2015 Feb; 25(3):558-61. PubMed ID: 25556100 [TBL] [Abstract][Full Text] [Related]
10. New derivatives of 5-aminolevulinic acid for photodynamic therapy: chemical synthesis and porphyrin production in in vitro and in vivo biological systems. Godal A; Nilsen NO; Klaveness J; Branden JE; Nesland JM; Peng Q J Environ Pathol Toxicol Oncol; 2006; 25(1-2):109-26. PubMed ID: 16566712 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological studies of 5-aminolevulinic acid-containing dendrimers for photodynamic therapy. Battah SH; Chee CE; Nakanishi H; Gerscher S; MacRobert AJ; Edwards C Bioconjug Chem; 2001; 12(6):980-8. PubMed ID: 11716689 [TBL] [Abstract][Full Text] [Related]
12. Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug. Curnow A; Perry A; Wood M Photodiagnosis Photodyn Ther; 2019 Mar; 25():157-165. PubMed ID: 30553949 [TBL] [Abstract][Full Text] [Related]
13. Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: new photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapy. Johnson RP; Chung CW; Jeong YI; Kang DH; Suh H; Kim I Int J Nanomedicine; 2012; 7():2497-512. PubMed ID: 22679363 [TBL] [Abstract][Full Text] [Related]
14. Design of Bifunctional Dendritic 5-Aminolevulinic Acid and Hydroxypyridinone Conjugates for Photodynamic Therapy. Zhou T; Battah S; Mazzacuva F; Hider RC; Dobbin P; MacRobert AJ Bioconjug Chem; 2018 Oct; 29(10):3411-3428. PubMed ID: 30249090 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of new 5-aminolevulinic acid derivatives as prodrugs of protoporphyrin for photodynamic therapy. Zhu W; Gao YH; Song CH; Lu ZB; Namulinda T; Han YP; Yan YJ; Wang LX; Chen ZL Photochem Photobiol Sci; 2017 Nov; 16(11):1623-1630. PubMed ID: 28933502 [TBL] [Abstract][Full Text] [Related]
16. Porphyrin profile in four human cell lines after supplementation with 5-aminolaevulinic acid and its methyl ester. Barron GA; Valentine R; Moseley H; Brancaleon L; Hill C; Woods JA Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):654-63. PubMed ID: 24284124 [TBL] [Abstract][Full Text] [Related]
17. Photosensitizer-loaded dendrimer-modified multi-walled carbon nanotubes for photodynamic therapy. Huang P; Lin J; Yang D; Zhang C; Li Z; Cui D J Control Release; 2011 Nov; 152 Suppl 1():e33-4. PubMed ID: 22195908 [No Abstract] [Full Text] [Related]
19. Induction of protoporphyrin IX by aminolaevulinic acid in actinic keratosis, psoriasis and normal skin: preferential porphyrin enrichment in differentiated cells. Smits T; van Laarhoven AI; Staassen A; van de Kerkhof PC; van Erp PE; Gerritsen MJ Br J Dermatol; 2009 Apr; 160(4):849-57. PubMed ID: 19175603 [TBL] [Abstract][Full Text] [Related]
20. Relation between intracellular location and photodynamic efficacy of 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Comparison between human glioblastoma cells and other cancer cell lines. Sailer R; Strauss WS; Wagner M; Emmert H; Schneckenburger H Photochem Photobiol Sci; 2007 Feb; 6(2):145-51. PubMed ID: 17277837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]